Jeffrey W. Clark

Oncology · 2001–2014

A researcher in the Science corpus: 7 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom Jeffrey W. Clark trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Rakesh K. Jain

Who trusts Jeffrey W. Clark overall

  1. Rakesh K. Jain

Papers from Jeffrey W. Clark's perspective

Ordered by how strongly the researchers Jeffrey W. Clark trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
  2. Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis (Science)
  3. Repopulation of cancer cells during therapy: an important cause of treatment failure (Nature Reviews. Cancer)
  4. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? (Nature Reviews. Cancer)
  5. Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics (Science)
  6. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis (Cancer Research)
  7. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. (New England Journal of Medicine)
  8. Tumour biology: Herceptin acts as an anti-angiogenic cocktail (Nature)
  9. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. (New England Journal of Medicine)
  10. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. (Journal of Clinical Oncology)

Their papers